SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001839882-22-002943
Filing Date
2022-02-14
Accepted
2022-02-14 17:29:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G during-sc13ga_123121.htm SC 13G/A 54771
  Complete submission text file 0001839882-22-002943.txt   56054
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90350 | Film No.: 22635227
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
During Matthew (Filed by) CIK: 0001704631 (see all company filings)

Type: SC 13G/A